Ana Paula Cabral de Faria (Ana Paula de Faria, Ana Paula de Faria)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 8

Top Topics

Arterial Hypertension

Top Venues

Journal of clinical hypertension (Greenwich, Conn.)

Arquivos brasileiros de cardiologia

Cardiovascular therapeutics

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Nayara Fraccari Pires, Helio Jose Coelho-Junior, Bruno Bavaresco Gambassi, Ana Paula Cabral de Faria, Alessandra Mileni Versuti Ritter, Carolina Souza Gasparetti, Mariana Rodrigues Pioli, Olívia Moraes Ruberti, Silvia Elaine Ferreira-Melo, Heitor Moreno Júnior, Bruno Rodrigues
Cardiovascular Autonomic Responses to Aerobic, Resistance and Combined Exercises in Resistance Hypertensive Patients. BioMed research international 2022 (2022)
Ana Paula Cabral de Faria, Alessandra M V Ritter, Arthur Santa-Catharina, Débora P Souza, Estephania P Naseri, Manoel B Bertolo, Mariana Rodrigues Pioli, Caio C Carvalho, Rodrigo Modolo, Heitor Moreno
Effects of Anti-TNF alpha Therapy on Blood Pressure in Resistant Hypertensive Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Arquivos brasileiros de cardiologia 116 (3) (2021)
Nayara Fraccari Pires, Helio Jose Coelho-Junior, Bruno Bavaresco Gambassi, Ana Paula Cabral de Faria, Alessandra Mileni Versuti Ritter, Catarina de Andrade Barboza, Silvia Elaine Ferreira-Melo, Bruno Rodrigues, Heitor Moreno Júnior
Combined Aerobic and Resistance Exercises Evokes Longer Reductions on Ambulatory Blood Pressure in Resistant Hypertension: A Randomized Crossover Trial. Cardiovascular therapeutics 2020 (2020)
Ana Paula Cabral de Faria, Alessandra Mileni Versuti Ritter, Carolina Souza Gasparetti, Nathália Batista Corrêa, Veridiana Brunelli, Aurelio Rochael Almeida, Nayara Fraccari Pires, Rodrigo Modolo, Heitor Moreno Júnior
A Proposed Inflammatory Score of Circulating Cytokines/Adipokines Associated with Resistant Hypertension, but Dependent on Obesity Parameters. Arquivos brasileiros de cardiologia 112 (4) (2019)
Mariana Rodrigues Pioli, Ana Paula Cabral de Faria
Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments? Current hypertension reports 21 (12) (2019)
Beatriz Moreno, Ana Paula Cabral de Faria, Alessandra Mileni Versuti Ritter, Lara Buonalumi Tacito Yugar, Silvia Elaine Ferreira-Melo, Rivadavio Amorim, Rodrigo Modolo, André Fattori, Juan Carlos Yugar-Toledo, Antonio Coca, Heitor Moreno
Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. Journal of clinical hypertension (Greenwich, Conn.) 20 (5) (2018)
Arthur Santa Catharina, Rodrigo Modolo, Alessandra Mileni Versuti Ritter, Thiago Quinaglia, Rivadávio Fernandes Batista de Amorim, Heitor Moreno, Ana Paula Cabral de Faria
Acute Sildenafil Use Reduces 24-Hour Blood Pressure Levels in Patients With Resistant Hypertension: A Placebo-Controlled, Crossover Trial. Journal of clinical hypertension (Greenwich, Conn.) 18 (11) (2016)
Andrea R Sabbatini, Natalia R Barbaro, Ana Paula Cabral de Faria, Rodrigo Modolo, Alessandra Mileni V Ritter, Claudio Pinho, Rivadavio Fernandes Batista Amorim, Vanessa Fontana, Heitor Moreno
Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension. Journal of clinical hypertension (Greenwich, Conn.) 18 (10) (2016)
Alessandra M V Ritter, Ana Paula Cabral de Faria, Vanessa Fontana, Rodrigo Modolo, Heitor Moreno
Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics. Journal of clinical hypertension (Greenwich, Conn.) 18 (2) (2015)